Laura M. Spring
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
- Oncology 84
- HER2/EGFR in Cancer Research 35
- Cancer Treatment and Pharmacology 28
- Cancer Cells and Metastasis 7
- Cancer Immunotherapy and Biomarkers 7
-
- Breast Cancer Treatment Studies 32
- Cancer Genomics and Diagnostics 23
- Co-authors
- Aditya Bardia (88 shared papers)Beverly Moy (57 shared papers)Seth A. Wander (25 shared papers)Steven J. Isakoff (46 shared papers)Leif W. Ellisen (38 shared papers)Fabrice André (3 shared papers)Mark L. Zangardi (7 shared papers)Nicholas C. Turner (2 shared papers)
- Journals
- Journal of Clinical Oncology (34 papers)Cancer Research (25 papers)Breast Cancer Research and Treatment (8 papers)The Oncologist (5 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Laura M. Spring
126 papers receiving 3.6k citations
Laura M. Spring's Hit Papers
Peers
Comparison fields: 5 of 108
- Cancer Research 1.0k
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.2k
- Genetics 251
- Radiology, Nuclear Medicine and Imaging 322
Countries citing papers authored by Laura M. Spring
This map shows the geographic impact of Laura M. Spring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura M. Spring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura M. Spring more than expected).
Fields of papers citing papers by Laura M. Spring
This network shows the impact of papers produced by Laura M. Spring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura M. Spring. The network helps show where Laura M. Spring may publish in the future.
Co-authors
The 25 scholars most cited alongside Laura M. Spring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models Hit paper breakdown → | 2018 | 429 |
| 2 | Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future Hit paper breakdown → | 2020 | 333 |
| 3 | 2016 | 277 | |
| 4 | Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer Hit paper breakdown → | 2017 | 262 |
| 5 | ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer Hit paper breakdown → | 2021 | 210 |
| 6 | 2021 | 163 | |
| 7 | 2019 | 130 | |
| 8 | 2011 | 126 | |
| 9 | 2017 | 121 | |
| 10 | 2020 | 115 | |
| 11 | 2017 | 91 | |
| 12 | 2023 | 86 | |
| 13 | 2018 | 78 | |
| 14 | 2019 | 69 | |
| 15 | Targeting the cyclin D-cyclin-dependent kinase (CDK) 4/6-retinoblastoma pathway with selective CDK 4/6 inhibitors in hormone receptor-positive breast cancer: rationale, current status, and future directions. | 2016 | 68 |
| 16 | 2021 | 66 | |
| 17 | 2019 | 50 | |
| 18 | 2020 | 49 | |
| 19 | 2021 | 45 | |
| 20 | 2022 | 41 |
About Laura M. Spring
Laura M. Spring is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 133 papers that have together received 3.6k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (46 papers), HER2/EGFR in Cancer Research (35 papers), Breast Cancer Treatment Studies (32 papers), Cancer Treatment and Pharmacology (28 papers), Cancer Genomics and Diagnostics (23 papers), Cancer Cells and Metastasis (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.2k citations), Genetics (251 citations) and Radiology, Nuclear Medicine and Imaging (322 citations). Laura M. Spring has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Aditya Bardia, Beverly Moy, Seth A. Wander, Steven J. Isakoff, Leif W. Ellisen, Fabrice André, Mark L. Zangardi, Nicholas C. Turner, Jamie O. Brett and Kerry L. Reynolds. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment, The Oncologist and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.